2018
DOI: 10.3389/fped.2018.00056
|View full text |Cite
|
Sign up to set email alerts
|

Non-Invasive Brain Stimulation in Children With Unilateral Cerebral Palsy: A Protocol and Risk Mitigation Guide

Abstract: Non-invasive brain stimulation has been increasingly investigated, mainly in adults, with the aims of influencing motor recovery after stroke. However, a consensus on safety and optimal study design has not been established in pediatrics. The low incidence of reported major adverse events in adults with and without clinical conditions has expedited the exploration of NIBS in children with paralleled purposes to influence motor skill development after neurological injury. Considering developmental variability i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 87 publications
(73 reference statements)
1
23
0
1
Order By: Relevance
“…In this regard, another major limitation of the present study is the absence of the assessment of the neurophysiological status of our UCP participants, which precluded the evaluation of tDCS effects on cortical responses, as well as of the relationship between tDCS-induced behavioral gains and underlying neurophysiology. In the developing brain with neurologic injury, motor outcomes and tDCS effects are both related to differences in the corticospinal circuitry [15, 26, 46]. Finally, the development of specific guidelines for the application of tDCS in the pediatric population could facilitate recruitment and standardization on the use and management of tDCS [44] and potentially lead to a greater role as a therapeutic tool for neurodevelopmental rehabilitation.…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, another major limitation of the present study is the absence of the assessment of the neurophysiological status of our UCP participants, which precluded the evaluation of tDCS effects on cortical responses, as well as of the relationship between tDCS-induced behavioral gains and underlying neurophysiology. In the developing brain with neurologic injury, motor outcomes and tDCS effects are both related to differences in the corticospinal circuitry [15, 26, 46]. Finally, the development of specific guidelines for the application of tDCS in the pediatric population could facilitate recruitment and standardization on the use and management of tDCS [44] and potentially lead to a greater role as a therapeutic tool for neurodevelopmental rehabilitation.…”
Section: Discussionmentioning
confidence: 99%
“…Those participants who responded affirmatively via email were subsequently contacted via telephone and asked to respond to 20 questions regarding their subjective assessment of their current neurological health (see Supplementary Material for questionnaire). This questionnaire is a variant of the Participant Report of Symptoms questionnaire that has previously been used in other non-invasive neuromodulation studies 45,46 . If there was a positive response to a question indicating perceived experience of the symptom, participants were then asked to rank the symptom severity from 2-4 (1 = absent) where 2 = mild, 3 = moderate and 4 = severe.…”
Section: Methodsmentioning
confidence: 99%
“…It is the purpose of this paper to provide an initial assessment of the symptoms and minor adverse events and safety of single element focused ultrasound for human neuromodulation as there is little research on participant perceived tolerance and report of symptoms. Here, we report on the findings of a variant of the Participant Report of Symptoms questionnaire 45,46 assessing participants' perceived tolerance to participation in LIFU and their perceived relation of any symptoms to the ultrasound intervention. Of a group of 120 queried, a total of (N = 64) consented to completing the questionnaire at various time points from immediately post-experiment out to 22 months.…”
mentioning
confidence: 99%
“…However, although there has been considerable investigation of the effectiveness of tDCS for adult stroke, the findings cannot be assumed to translate directly into children and adolescents with CP, due to differences in brain size, maturity, anatomy and reorganisation. The application of tDCS in this population appears to be safe [4] and safety guidelines have been developed [5]. This narrative review therefore focuses on the neurophysiological and clinical findings with use of tDCS in children and adolescents (6–21 years) with CP.…”
Section: Introductionmentioning
confidence: 99%